Immune factors in human cancer: malignant melanomas, skeletal and soft tissue sarcomas.
D000230:Adenocarcinoma / Q000276:immunology; D000818:Animals; D000906:Antibodies; D000917:Antibody Formation; D000918:Antibody Specificity; D000937:Antigen-Antibody Reactions; D000941:Antigens / Q000032:analysis*; D000951:Antigens, Neoplasm / Q000032:analysis; D001323:Autoantibodies / Q000032:analysis; D001859:Bone Neoplasms / Q000276:immunology*; D002294:Carcinoma, Squamous Cell / Q000276:immunology; D002460:Cell Line; D002471:Cell Transformation, Neoplastic; D002478:Cells, Cultured / Q000276:immunology; D003168:Complement Fixation Tests; D046508:Culture Techniques; D003601:Cytotoxicity Tests, Immunologic; D005260:Female; D005455:Fluorescent Antibody Technique; D000882:Haplorhini / Q000196:embryology; D006367:HeLa Cells / Q000276:immunology; D006689:Hodgkin Disease / Q000276:immunology; D006801:Humans; D005779:Immunodiffusion; D007074:Immunoglobulin G / Q000032:analysis; D007136:Immunoglobulins / Q000032:analysis; D007938:Leukemia / Q000276:immunology; D008080:Liposarcoma / Q000276:immunology; D008168:Lung / Q000196:embryology; D008207:Lymphatic Metastasis; D008545:Melanoma / Q000276:immunology*; D009362:Neoplasm Metastasis; D009365:Neoplasm Regression, Spontaneous; D009369:Neoplasms / Q000276:immunology*; D009858:Oncogenic Viruses / Q000276:immunology; D012516:Osteosarcoma / Q000276:immunology; D012509:Sarcoma / Q000276:immunology*
D000906:Antibodies; D000941:Antigens; D000951:Antigens, Neoplasm; D001323:Autoantibodies; D007074:Immunoglobulin G; D007136:Immunoglobulins